Health Innovation

We are de-risking biomedical innovations, turning biomedical knowledge into social and economic value.

Health Innovation Assessment

Mercury Pharmaceuticals

Innovators and start-ups in healthcare and biotech are experts in their innovation’s scientific and technical domain but often struggle with navigating the complex world of the healthcare industry.

If you want to objectively show the advantages and competitiveness of your innovation to potential investors, future users, (reimbursement) payers or even the media, you can greatly benefit from Mercury Pharmaceuticals’s Health Innovation Assessment solution.

By making use of robust methods to collect and analyse data, Health Innovation Assessment (HIA) aims to comprehensively assess the added value of (bio-)medical and healthcare innovations. HIA takes into account true multi-stakeholder perspectives on value assessment and the realm of marketplace decision making.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

STAY INFORMED!

Prebiotic sodas may contain less fiber and more sugar

25

Jul 2026

Prebiotic sodas may contain less fiber and more sugar

Prebiotic sodas have become more popular in recent years, with a wave of new products promising gut health benefits and low-calorie enjoyment.

Planetary Health Diet lowers cardiovascular risk in older women

25

Jul 2026

Planetary Health Diet lowers cardiovascular risk in older women

A 20-year study of more than 65,000 postmenopausal women found that higher adherence to the Planetary Health Diet was associated with a lower risk of overall cardiovascular disease, coronary heart disease, stroke and heart failure.

FDA-issued sodium targets appear to have minimal impact

25

Jul 2026

FDA-issued sodium targets appear to have minimal impact

In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024.

Expert consensus advances evidence-based orthodontic care for adult patients

24

Jul 2026

Expert consensus advances evidence-based orthodontic care for adult patients

Alveolar bone defects and protrusive facial deformities affect a considerable portion of the population and may increase the risk of other complications.

Why Us?

KNOWLEDGE OF RESEARCH ENVIRONMENT

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.

UNDERSTANDING INDUSTRIAL NEEDS

Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.

FOCUSED PROJECT MANAGEMENT

Smart approach to project management that helps speed up development stages and decision making.

INVESTMENT CAPABILITY

Availability of own investment up to 2m€ per project allows us to reach the next value milestone.